Los Angeles, CA, United States of America

Carmen Bertoni

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: University of California. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carmen Bertoni. Retrieved from https://idiyas.com/inventor/carmen-bertoni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Carmen Bertoni: Innovator in Pharmaceutical Science

Introduction

Carmen Bertoni is a distinguished inventor based in Los Angeles, California. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative prodrug compounds. With a total of three patents to her name, her work focuses on addressing premature nonsense mutations in genetic coding.

Latest Patents

Carmen's latest patents include groundbreaking research on read-through compound prodrugs that suppress premature nonsense mutations. These patents detail the formulation of compounds that can effectively address premature termination codons. The compounds are described as having specific chemical structures, including Formula Ia, and can exist in various forms such as salts, solvates, and esters.

Career Highlights

Carmen Bertoni is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its potential to improve therapeutic outcomes for genetic disorders caused by premature mutations.

Collaborations

Carmen collaborates with notable colleagues, including Jasbir Singh and Richard A. Gatti, who contribute to her research initiatives and enhance the impact of her work.

Conclusion

Carmen Bertoni's innovative contributions to pharmaceutical science exemplify the importance of research in combating genetic disorders. Her patents reflect a commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…